Vaginal dilators market seen reaching $37.66 billion by 2030

The Business Research Company says the vaginal dilators market is growing on rising awareness of women’s health, more gynecological conditions and new device technology. The market is projected to rise from $25.21 billion in 2025 to $37.66 billion by 2030, with North America holding the largest share in 2025.

Why it matters: - The vaginal dilators market is expanding as more patients and clinicians seek therapies for pelvic floor disorders and other gynecological conditions. - Faster growth in home-based care, telemedicine and personalized devices could change how pelvic rehabilitation is delivered. - The market’s projected rise to $37.66 billion by 2030 signals continued commercial demand in women’s health devices.

What happened: - The Business Research Company released a vaginal dilators market report on Sept. 2, 2026. - The report estimates the market will grow from $25.21 billion in 2025 to $27.39 billion in 2026. - The report projects the market will reach $37.66 billion by 2030. - North America held the largest share of the market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - Vaginal dilators are medical instruments used to gently stretch and widen the vaginal canal. - The devices come in multiple sizes and shapes to match different therapeutic needs. - Healthcare professionals typically supervise use to support proper technique and address individual medical concerns. - Growth in 2025 and 2026 is tied to rising prevalence of pelvic floor disorders, greater awareness of post-surgical therapies, medical-grade silicone innovation, more gynecological clinics and stronger focus on women’s sexual health. - The report links broader market expansion to increasing gynecological conditions, including disorders and diseases affecting the female reproductive system. - Lifestyle shifts, delayed childbearing, environmental toxins and higher infection rates are cited as contributing factors. - Cancer Australia reported about 6,963 new gynecological cancer diagnoses in 2024. - Cancer Australia also estimated a 1 in 23 chance, or 4.3%, that a woman will develop gynecological cancer by age 85.

Between the lines: - The report points to a shift from clinic-only therapy toward more personalized and at-home treatment models. - Adoption of 3D-printed dilators and mobile health tools suggests device makers are pairing physical products with digital monitoring. - The market outlook also reflects growing normalization of pelvic floor rehabilitation as part of women’s health care. - The report highlights 3D-printed custom dilators, AI-powered therapy monitoring, multi-size and multi-material options, telemedicine integration and home-based pelvic floor therapy as key trends.

What's next: - The market is expected to keep growing through 2030 at an 8.3% CAGR. - Wider use of telemedicine in gynecological care could increase demand for remote-compatible therapy devices. - More awareness campaigns may further support uptake of pelvic floor rehabilitation products. - The report’s 2026 editions add market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards, market hotspots infographics and updated trend analysis.

The bottom line: - The vaginal dilators market is moving from a niche therapy category toward a broader women’s health device segment with steady global growth and more digital integration.